The Dendreon Alumni: Where Are They Now?

3/31/10Follow @xconomy

(Page 2 of 4)

Danielle Brown, oncology account manager, Amgen

Jamal Brown, director of quality, The Medicines Company

Michelle Burris, chief operating officer, Trubion Pharmaceuticals

Jim Caggiano, vice president of sales and marketing, Allergan

Liz Cardwell, quality assurance/regulatory consultant

Feng Chen, senior associate scientist, MDRNA

Nathan Christensen, senior purchasing agent, Trubion Pharmaceuticals

Douglas Clark, technical consultant, Scherer & Associates

Matthew Croughan, George B. and Joy Rathmann professor, director of the Amgen Bioprocessing Center, Keck Graduate Institute [Added: 5:40 pm, 5/10/10]

Rick Dejong, senior systems and reporting analyst, Marchex

Justine Dell’Aringa, senior associate scientist, Amgen

Nancy Deroux, regulatory operations manager, Novartis Vaccines

Michael Diegel, scientist, Revalesio [Added: 3:12 pm, 9/27/10]

Petra Duterrow, senior buyer, F5

Julie Eastland, chief financial officer, VLST

Deborah Elvins, managing member, Adkins, Plant, Elvins & Black

John Emswiler, scientist, Micronics

Ken Farah, managing director, BiologicResponse [Added: 8:50 pm, 4/1/10]

Richard Gaeto, vice President, CMC operations, ZymoGenetics [Added: 3:20 pm, 3/31/10]

Pete Garcia, chief financial officer, MDRNA

Dennis George, arbitrator

Monique Greer, vice president corporate communications/investor relations, Allos Therapeutics

Helen Halloran, IP and contract paralegal, office support

Lori Hansen, director of project management, Seattle Genetics

Wes Hargraves, chief financial officer-Americas, Intec Telecom

Christopher Henney, chairman of the board, Oncothyreon, director, AVI Biopharma

Rob Hershberg, co-founder, executive vice president of R&D, VentiRx Pharmaceuticals

Rob Hill, senior medical writing specialist, Gilead Sciences

Lisa Johnson, graduate research assistant, microbiology, immunology and cancer biology Ph.D. program, University of Minnesota

Lori Jones, biotechnology professional

Jelle Kylstra, independent biotechnology professional

Reiner Laus, CEO, BN ImmunoTherapeutics … Next Page »

Single Page Currently on Page: 1 2 3 4 previous page

By posting a comment, you agree to our terms and conditions.

  • Rich Gaeto
  • Bryan Monroe

    Hi Luke. I was missing from the list. My group was responsible for all of the fermentation scaleup and clinical manufacturing for Provenge. I was employee #36. My first hire into the group was Mara Boykin, who had worked for me previously at ZymoGenetics in a similar role. I have been at Life Technologies since 2002.

    Bryan D. Monroe
    Process Science Fellow
    Life Technologies